Trademarkia Logo

Australia

AU$
RIMPOVIZ
Protected: Registered/protected

Last updated on 29 Apr 2025

Owner Info

Biogen International GmbH

Neuhofstrasse 30

Baar, SWITZERLAND

Serial Number

2280194 filed on 1 Jun 2022

Correspondent

Douglas A. Rettew

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP,

901 New York Avenue NW,

UNITED STATES OF AMERICA

RIMPOVIZ

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of eye diseases, disorders, and conditions; ophthalmologic pharmaceutical preparations.

Mark Details


Serial Number

2280194

Registered On

1 Jun 2022

Renewal On

1 Jun 2032

Mark Type

WORD

Priority Claim (Convention Details)


Date

16 Dec 2021

Mark Type

EM

Legal History


Show more

Status DateAction Taken
29th Apr 2025Status change to Voided
1st Mar 2025Full Assignment - Subsequent Owner Registered Published
27th Feb 2025Full Assignment Requested
9th Sept 2022International Registration in Australia Protected correspondence sent
8th Sept 2022IP Right Registration Published
8th Sept 2022Status change to Registered/Protected
2th Jul 2022Application Accepted correspondence sent
1st Jul 2022IP Right has been Examined
1st Jul 2022IP Right Acceptance Published
1st Jul 2022Status change to Accepted